LONDON, May 24, 2018 /PRNewswire/ --
Andrea MA Omengue, Eugene Sobngwi, Mesmin Dehayem, Eric V Balti, Anne MO Boli,Simeon P Choukem, Jean F Gautier, Jean-Claude Mbanya
(Logo: http://mma.prnewswire.com/media/515766/Touch_Medical_Logo.jpg )
European Endocrinology. 2018;14(1):44-46 DOI: https://doi.org/10.17925/EE.2018.14.1.44
The full peer-reviewed, open-access article is available here:
Disclosure: Andrea MA Omengue, Eugène Sobngwi, Mesmin Dehayem, Eric V Balti, Anne MO Boli, Simeon P Choukem, Jean F Gautier and Jean-Claude Mbanya have nothing to declare in relation to this article. No funding was received in the publication of this article.
touchENDOCRINOLOGY (a division of Touch Medical Media) publishes
European Endocrinology, a peer-reviewed, open access, bi-annual journal specialising in the publication of balanced and comprehensive review articles written by leading authorities to address the most important and salient developments in the field of endocrinology. The aim of these reviews is to break down the high science from 'data-rich' primary papers and provide practical advice and opinion on how this information can help physicians in the day to day clinical setting. Practice guidelines, symposium write-ups, case reports, and original research articles are also featured to promote discussion and learning amongst physicians, clinicians, researchers and related healthcare professionals.
For inquires please contact: Nicola Cartridge - Editorial Director email@example.com +44-(0)-207-193-3186
"Leading the Debate on the Advances in Healthcare" "Touch Medical Media is a trading name of Touch Digital Media Limited, a private limited company registered in England and Wales at The White House Mill Road, Goring, Reading, England, RG8 9DD with registered number 08197142".
Subscribe to our Free Newsletters!
Exfoliative dermatitis or erythroderma is a skin condition where the skin becomes reddened and ...
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...View All